Literature DB >> 20937319

Seroprevalence of rubella in female migrant factory workers in Shenzhen, China.

Jin Mou1, Sian M Griffiths, Hildy F Fong, Qinghua Hu, Xu Xie, Yaqing He, Hanwu Ma, Jinquan Cheng.   

Abstract

BACKGROUND: Rubella remains a common disease in Mainland China and is a major cause of severe birth defects from Congenital Rubella Syndrome (CRS). Rubella-containing vaccines were not included in China's National Expanded Program of Immunization (NEPI) until December 2007. In Shenzhen, women of childbearing age make up a large percentage of its migrant factory worker population. Understanding their immunity to rubella is critical in furthering efforts towards rubella vaccination programs.
OBJECTIVES: To investigate the seronegativity of rubella antibodies and evaluate potential associates of rubella immunity among female migrant factory workers in Shenzhen, China. SUBJECTS AND METHODS: Serum samples were collected from 518 female migrant workers, aged 18-55, working in 44 randomly selected factories in Shenzhen, China during May through June of 2009. Samples were tested for Rubella Immunoglobulin G (IgG) using a commercial Enzyme-linked immunosorbant assay kit. Self-reported vaccination histories and socio-demographic information were also collected.
RESULTS: Of 518 female workers, 402 (77.6%) were immune to rubella. Significant differences in seronegativity were dependent on region of origin, being without a job contract, age group, marital status and seronegativity of measles.
CONCLUSIONS: Seroprevalence of antibodies to rubella in Shenzhen, China amongst female migrant workers is too low to provide immunity in the population. Given the high numbers of women of childbearing age amongst Shenzhen migrant factory workers coming from many provinces across China, local health authorities in Shenzhen should consider combining new rubella immunization programs with existing measles immunization efforts in this population.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937319     DOI: 10.1016/j.vaccine.2010.09.082

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Emergence and continuous evolution of genotype 1E rubella viruses in China.

Authors:  Zhen Zhu; Aili Cui; Huanhuan Wang; Yan Zhang; Chunyu Liu; Changyin Wang; Shujie Zhou; Xia Chen; Zhenying Zhang; Daxin Feng; Yan Wang; Haiyun Chen; Zhengfan Pan; Xiangjie Zeng; Jianhui Zhou; Shuang Wang; Xin Chang; Yue Lei; Hong Tian; Yang Liu; Shunde Zhou; Jun Zhan; Hui Chen; Suyi Gu; Xiaoling Tian; Jianfeng Liu; Ying Chen; Hong Fu; Xiuhui Yang; Huanying Zheng; Leng Liu; Lei Zheng; Hui Gao; Jilan He; Li Sun; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome.

Authors:  Hanqing He; Rui Yan; Xuewen Tang; Yang Zhou; Xuan Deng; Shuyun Xie
Journal:  BMC Infect Dis       Date:  2016-11-30       Impact factor: 3.090

3.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

4.  Rubella immunity in women of childbearing age, eight years after the immunization program in iran.

Authors:  Rahim Barari Sawadkohi; Amin Zarghami; Fatemeh Izadpana; Mohammad Pournasrollah
Journal:  Iran Red Crescent Med J       Date:  2014-07-05       Impact factor: 0.611

Review 5.  Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review.

Authors:  Emilia Vynnycky; Elisabeth J Adams; Felicity T Cutts; Susan E Reef; Ann Marie Navar; Emily Simons; Lay-Myint Yoshida; David W J Brown; Charlotte Jackson; Peter M Strebel; Alya J Dabbagh
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

Review 6.  Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-07-17

7.  Rubella seroprevalence among pregnant women in Beijing, China.

Authors:  Qinghong Meng; Jie Luo; Lijun Li; Wei Shi; Jinqian Yu; Yingjie Shen; Li Li; Yajuan Wang; Kaihu Yao
Journal:  BMC Infect Dis       Date:  2018-03-15       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.